Naloxone, Flumazenil and Dantrolene as Antidotes
Seiten
1994
Cambridge University Press (Verlag)
978-0-521-45459-9 (ISBN)
Cambridge University Press (Verlag)
978-0-521-45459-9 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This volume describes an international project to evaluate the use of antidotes and other agents used in the management of poisoned patients.
The first volume provides an introduction to the series and reviews three antidotes: naloxone, a specific opioid antagonist used in the treatment of opiate poisoning; flumazenil, used to reverse the sedative, anti-convulsant and muscle-relaxant effects of benzodiazepines; and dantrolene sodium, used in the treatment of malignant hyperpyrexia and hyperthermia, neuroleptic malignant syndrome and hypercatabolic syndrome. This important new series arises from a coordinated programme of the International Programme on Chemical Safety (IPCS) (ILO/UNEP/WHO) and the Commission of the European Communities (CEC) to evaluate the efficacy of and indications for clinical and field use of these antidotes and other agents to treat poisoning.
The first volume provides an introduction to the series and reviews three antidotes: naloxone, a specific opioid antagonist used in the treatment of opiate poisoning; flumazenil, used to reverse the sedative, anti-convulsant and muscle-relaxant effects of benzodiazepines; and dantrolene sodium, used in the treatment of malignant hyperpyrexia and hyperthermia, neuroleptic malignant syndrome and hypercatabolic syndrome. This important new series arises from a coordinated programme of the International Programme on Chemical Safety (IPCS) (ILO/UNEP/WHO) and the Commission of the European Communities (CEC) to evaluate the efficacy of and indications for clinical and field use of these antidotes and other agents to treat poisoning.
Erscheint lt. Verlag | 13.1.1994 |
---|---|
Reihe/Serie | International Programme on Chemical Safety: Evaluation of Antidotes |
Verlagsort | Cambridge |
Sprache | englisch |
Maße | 178 x 255 mm |
Gewicht | 370 g |
Themenwelt | Studium ► 2. Studienabschnitt (Klinik) ► Pharmakologie / Toxikologie |
ISBN-10 | 0-521-45459-X / 052145459X |
ISBN-13 | 978-0-521-45459-9 / 9780521454599 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Hardcover (2024)
Thomas Karow (Verlag)
CHF 79,95
Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 138,60